Microbiome & Artificial Intelligence: The K4I 12th EU Innovation Summit report

A new study helps to explain how nerve cells sense the microbes in the gut and how they coordinate their function with other tissues in the digestive tract.

This K4I 12th European Innovation Summit has been a great and most unique opportunity for Probionova in partnership with Arches to create a direct and propositive dialogue with the European Institutional key interlocutors.

The Meps Mr. Sean Kelly and Mrs. Maria da Graça Carvalho hosted the session.

The main target today was to generate ATTENTION, INTEREST and REACTIONS towards the subject of MICROBIOME & ARTIFICIAL INTELLIGENCE.

The moderator Roland Strauss, Director of K4I platform introduced the Meps hosting the event.

Sean Kelly
Sean Kelly

Sean Kelly highlighted the relevance of technologies and novel applications for standing of Europe into a global context, to strenghten internal resources and becoming more competitive; while Maria da Graça Carvalho outlined the importance of translating research achievements into novel clinical practices and methods, especially in the context of precision/personalized medicine. Together with the importance of Institutionalized partnership, including in the future pipeline Innovative Health Initiative as well as, in particular a stronger EU/Africa partnership on global health.

She also confirmed that the new HORIZON EUROPE will start soon beginning of January with a consistent budget allocation also on health related projects.

First introduction on the background and concept behind the project was given by Michela Bianco Prevot, mainly highlighting the importance of creating/opening a dialogue but also focusing on how Covid-19 has accellerated the need to “change the paradigm” and how the ONE HEALTH CONCEPT involving environment, soil, plant, animal and HUMAN is strictly correlated to the Microbiome world.

Maria da Graça Carvalho
Maria da Graça Carvalho

Second intervention was held by Marco Boccarusso, R&D Director of Probionova, pointing out how to create impact as a disruptive start up in the European context, sharing its path and skills as per Research, Innovation and Technology, ranging from applied microbiology to clinical medicine, developing new evidence-based probiotics as well as the next generation live biotherapeutics.

Another remark has been adressed to the fact that consumption of probiotics helps in reducing the intake of antibiotics, lowering the impact of the negative side effect of antimicrobial resistance spreading.

Last intervention was performed by prof. Vassilios Fanos, who deeply illustrated the multi omics approach as the future tools for personalized medicine thorugh the tools Artificial Intelligence can offer as per prediction, prevention and treatment, thanks to the BIG DATA collection and long term analysis (LONG DATA) thanks to which QUOTE “Doctors will not be relaced by artifiical intelligence; however, those who use it will replace whose who do not” (Bertalan Meskò) .

«We are proud to say we reached our goal, by creating an interactive discussion as the topic – generated a high and deep involvement of the audience» said Michela Bianco Prevot at the end of the session.

«The most important outcome is the direct request to continue this debate, due to the strong impact of the topic at EU level for future opportunities, possibly via the organisation of a lunch debate with other key Meps to be involved, possibly in Brussels at the earliest occasion» Marco Boccarusso acknowledge with satisfaction after the debate.